----
Current ValuationThe current P/E ratio is -0.19, above the reasonable range, cheaper than 18.77% of the time in the past 1 years, and the industry ranks 23/54, the industry Median -0.19.
-0.186xP/E
$2.73Stock price
$-14.64Earnings per share
-0.186xP/E
Stock price$2.73Earnings per share$-14.64
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -0.39x
- Typical range
- -0.89x–-0.19x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
054108162216
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
SSDOYUSShiseido | -71.37x | -- | $9.36B |
COTYUSCoty | -4.57x | 115.33% | $2.83B |
EPCUSEdgewell Personal Care | -14.29x | 79.87% | $1.33B |
HNSTUSHonest | -42.87x | 166.37% | $521.40M |
USNAUSUSANA Health Sciences | -12.10x | 205.17% | $268.28M |
NUSUSNu Skin | -1.11x | 248.43% | $239.49M |
YSGUSYatsen | -7.54x | 34.19% | $227.00M |
GLASUSGlass House Brands | -3.35x | -- | $214.87M |
MEDUSMedifast | -5.31x | 44.71% | $136.07M |
MLKMFUSWALDENCAST PLC | -0.63x | -- | $105.05M |
SKINUSSkinHealth | -2.54x | 0.29% | $72.20M |
UPXIUSUpexi | -0.23x | -- | $55.86M |
BHSTUSBioHarvest Sciences | -3.44x | 12.08% | $38.08M |
ZIVOUSZivo Bioscience | -3.01x | -- | $25.53M |
DQWSUSDSwiss, Inc. | -70.67x | -- | $17.38M |
MTEXUSMannatech | -2.23x | -- | $16.48M |
DSYUSBig Tree Cloud | -- | -- | $15.78M |
HYEXUSHealthy Extracts Inc. | -16.77x | -- | $14.74M |
GLUCUSGlucose Health, Inc. | -- | -- | $12.35M |
CABRUSCaring Brands | -1.10x | -- | $10.89M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
